The Efficacy of Thoracoabdominal Nerve Block With Serratus Intercostal Plane and Rectus Sheath Block in Cholecystectomy
NCT ID: NCT06241794
Last Updated: 2025-03-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2024-02-05
2024-08-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Transversus Abdominis Plan Block and Recto-Intercostal Fascial Plan Block in Laparoscopic Cholecystectomy
NCT06673524
"The Efficiency of Laparoscopic-assisted Transversus Abdominis Plane Block for Post-laparoscopic Cholecystectomy Pain
NCT04641403
Postoperative Analgesic Efficacy of Recto Intercostal Nerve Block
NCT07003698
Modified Thoracoabdominal Nerve Block With Perichondrial Approach in Laparoscopic Cholecystectomy Surgery
NCT06595875
Analgesic Effect of M-TAPA and TAPB on Laparoscopic Cholesistectomy
NCT06662617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Cholecystectomy is a common surgical procedure performed worldwide for acute cholecystitis. The management of acute cholecystitis is divided into medical and surgical approaches. Medical management includes bed rest, analgesic agents, antibiotic therapy, and intravenous fluid replacement. Surgical management involves a procedure called cholecystectomy, which is the surgical removal of the gallbladder. This operation can be performed using open surgery or laparoscopic techniques. The laparoscopic technique is superior to open surgery in terms of less pain at incision sites, shorter hospital stay, improved quality of life, and faster recovery times. However, laparoscopic cholecystectomy (LC), despite being a minimally invasive surgery, can still cause moderate to severe pain.
Severe pain can lead to delayed postoperative ambulation, decreased patient satisfaction, the development of chronic pain, and is associated with increased lung and heart complications. Postoperative pain in LC can arise from various causes. While a significant portion of postoperative pain in LC is attributed to incision sites (50-70%), it also originates from pneumoperitoneum (20-30%) and cholecystectomy (10-20%). Multimodal analgesia, including non-steroidal anti-inflammatory drugs, paracetamol, opioids, local anesthetics, and various regional anesthesia techniques, should be considered for pain control. Opioids may cause side effects such as postoperative nausea and vomiting (PONV), constipation, and respiratory depression. Neuraxial analgesia is rarely used in LC due to possible complications and technical difficulties.
The use of interfascial plane blocks under ultrasound guidance, considered easy and safe, has increased in LC surgery. The thoracoabdominal plane block (TAPA) applied through a perichondrial approach, showing that it spreads to a broader dermatomal area than the transversus abdominis plane (TAP) block and the oblique subcostal transversus abdominis plane (OSTAP) block. The rectus sheath block (RSB) is used to provide postoperative analgesia after various surgeries, including laparoscopic and upper abdominal surgeries. Ultrasound-guided RSB in LC has significantly reduced postoperative pain.
In this study, the combination of RSB and SIPB was planned to be applied to enhance the effectiveness and quality of analgesia in the mid-abdomen. Patients will be asked to fill out the Quality of Recovery-15 (QoR-15) scale, a self-report questionnaire used to assess the quality of postoperative recovery, in the preoperative waiting area on the morning of the surgery and 24 hours after the surgery. The QoR-15 scale measures recovery quality in five areas: physical comfort, pain, physical independence, psychological support, and emotional state, providing a one-dimensional measurement of recovery quality with scores ranging from 0 to 150. A higher score indicates better recovery quality.
In this study, in laparoscopic cholecystectomy, one group will receive bilateral M-TAPA, and another group will receive bilateral RSB + right SIPB to investigate their superiority in terms of postoperative NRS (Numeric Rating Scale) score, opioid consumption, dermatomal spread, PONV score, and complications, aiming to determine which is more effective.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group M-TAPA
M-TAPA:
Aseptic conditions are ensured in the area where the block will be performed. Under ultrasound guidance, a linear probe at the sagittal plane and costochondral angle is used to identify the transversus abdominis, internal oblique, and external oblique muscles at the level of the 10th rib. To visualize the lower surface of the rib cartilage in the midline, a sagittal angle is applied with the probe in the direction of the costochondral angle at the edge of the 10th rib. Using a 22-G, 80-100 mm block needle with an in-plane technique, the needle is advanced cranially. The needle tip is directed towards the posterior surface of the 10th rib cartilage, underneath the condyle. Subsequently, 20 ml of 0.25% concentration bupivacaine is injected beneath the condyle. The same procedure will be applied to the opposite side using the same technique.
Group M-TAPA
Aseptic conditions are ensured in the area where the block will be performed. Under ultrasound guidance, a linear probe at the sagittal plane and costochondral angle is used to identify the transversus abdominis, internal oblique, and external oblique muscles at the level of the 10th rib. To visualize the lower surface of the rib cartilage in the midline, a sagittal angle is applied with the probe in the direction of the costochondral angle at the edge of the 10th rib. Using a 22-G, 80-100 mm block needle with an in-plane technique, the needle is advanced cranially. The needle tip is directed towards the posterior surface of the 10th rib cartilage, underneath the condyle. Subsequently, 20 ml of 0.25% concentration bupivacaine is injected beneath the condyle. The same procedure will be applied to the opposite side using the same technique.
Group Serratus Intercostal Plane Block and Rectus Sheath Block
Serratus intercostal plane block:The serratus anterior muscle and intercostal muscles are identified at the level of 8th rib along the right mid-axillary line.Using block needle,20 ml of 0.25% Bupivacaine is injected into the interfascial plane between these muscles.The SIPB will be performed only on right side.
Rectus sheath block:a linear probe is placed in a transverse position just above the umbilicus and slightly lateral to the midline.After visualizing the rectus abdominis muscle, posterior rectus sheath,and the hypoechoic space between them,block needle is advanced in-plane along the subcutaneous tissue.The needle is progressed until reaching the space between the epimysium of the muscle and the posterior rectus sheath, passing horizontally through the anterior rectus sheath of the rectus abdominis muscle.10 ml of 0.25% bupivacaine is injected.Adequate spread will lift the epimysium of the rectus abdominis muscle while displacing the posterior fascia and peritoneum downward
Group Serratus Intercostal Plane Block and Rectus Sheath Block
Serratus intercostal plane block:The serratus anterior muscle and intercostal muscles are identified at the level of 8th rib along the right mid-axillary line.Using block needle,20 ml of 0.25% Bupivacaine is injected into the interfascial plane between these muscles.The SIPB will be performed only on the right side.
Rectus sheath block:a linear probe is placed in a transverse position just above the umbilicus and slightly lateral to the midline.After visualizing the rectus abdominis muscle, posterior rectus sheath,and the hypoechoic space between them,block needle is advanced in-plane along the subcutaneous tissue.The needle is progressed until reaching the space between the epimysium of the muscle and the posterior rectus sheath, passing horizontally through the anterior rectus sheath of the rectus abdominis muscle.10 ml of 0.25% bupivacaine is injected.Adequate spread will lift the epimysium of rectus abdominis muscle while displacing the posterior fascia and peritoneum downward
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group M-TAPA
Aseptic conditions are ensured in the area where the block will be performed. Under ultrasound guidance, a linear probe at the sagittal plane and costochondral angle is used to identify the transversus abdominis, internal oblique, and external oblique muscles at the level of the 10th rib. To visualize the lower surface of the rib cartilage in the midline, a sagittal angle is applied with the probe in the direction of the costochondral angle at the edge of the 10th rib. Using a 22-G, 80-100 mm block needle with an in-plane technique, the needle is advanced cranially. The needle tip is directed towards the posterior surface of the 10th rib cartilage, underneath the condyle. Subsequently, 20 ml of 0.25% concentration bupivacaine is injected beneath the condyle. The same procedure will be applied to the opposite side using the same technique.
Group Serratus Intercostal Plane Block and Rectus Sheath Block
Serratus intercostal plane block:The serratus anterior muscle and intercostal muscles are identified at the level of 8th rib along the right mid-axillary line.Using block needle,20 ml of 0.25% Bupivacaine is injected into the interfascial plane between these muscles.The SIPB will be performed only on the right side.
Rectus sheath block:a linear probe is placed in a transverse position just above the umbilicus and slightly lateral to the midline.After visualizing the rectus abdominis muscle, posterior rectus sheath,and the hypoechoic space between them,block needle is advanced in-plane along the subcutaneous tissue.The needle is progressed until reaching the space between the epimysium of the muscle and the posterior rectus sheath, passing horizontally through the anterior rectus sheath of the rectus abdominis muscle.10 ml of 0.25% bupivacaine is injected.Adequate spread will lift the epimysium of rectus abdominis muscle while displacing the posterior fascia and peritoneum downward
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 18 and 65
* Body Mass Index (BMI) \<35
* Has read and accepted the informed consent form voluntarily
Exclusion Criteria
* Patients with a body mass index (BMI) \>35
* ASA 3-5 classification
* unable to use the NRS pain scoring system
* allergies to the used local anesthetic and specified analgesic drugs
* individuals declaring pregnancy or breastfeeding
* patients under 18 or over 65 years of age
* those with uncontrolled anxiety
* alcohol and drug addiction
* neuromuscular and peripheral nerve diseases
* using high-dose opioid drugs three days before surgery
* hepatic and renal insufficiency, coagulation disorders
* diabetes mellitus
* patients using anticoagulant drugs
* infections at the site of peripheral block needle entry
* those undergoing a second procedure along with laparoscopic cholecystectomy
* individuals with a history of abdominal surgery or trauma
* conversion of laparoscopic surgery to open surgery
* inability to communicate in Turkish
* NRS score above 7 for consecutive 4 hours despite the planned multimodal analgesia regimen
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hitit University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Güvenç Doğan
associated professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hitit University Erol Olcok Training and Research Hospital
Çorum, Center, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-172
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.